Refametinib, 1 mg

Refametinib, 1 mg

Refametinib (also known as a selective MEK1/2 inhibitor) supplied by STEMCELL Technologies. Used in research to inhibit the MAPK/ERK signaling pathway in cancer biology and cell-signaling studies. Supplied as a 1 mg solid for preparation of concentrated stocks (typically dissolved in DMSO); store per manufacturer recommendations and protect from light. For research use only; not for clinical or human use.